H.R. 8319: Keeping Individuals with Dialysis Needs Equipped through Year-round Remote Monitoring Act
The Keeping Individuals with Dialysis Needs Equipped through Year-round Remote Monitoring Act, also known as the KIDNEY Remote Monitoring Act, proposes changes to the Medicare program specifically to enhance remote monitoring services for individuals with end-stage renal disease (ESRD) who are undergoing home dialysis. Here are the main components of the bill:
Expanding Remote Monitoring Services
The bill amends the Social Security Act to broaden the scope of remote monitoring services provided by physicians. Key elements include:
- Inclusion of Additional Subparagraphs: The legislation modifies existing regulations to include new payment structures for remote monitoring services, allowing for greater flexibility in how these services are billed.
- Coverage for Home Dialysis: Payments for physiologic monitoring services will specifically cover patients with end-stage renal disease who are receiving home dialysis, indicating a focus on improving care for these individuals.
- Implementation Date: The new payment structure for these services would take effect starting January 1, 2028.
Objective of the Bill
The overall aim of the bill is to ensure that people with ESRD can access year-round remote monitoring, which may improve their health outcomes by enabling continuous care and oversight from healthcare providers. By enhancing remote monitoring services, the bill seeks to support the health needs of individuals relying on home dialysis treatments.
Potential Impact
By expanding these services, the legislation could facilitate better management of the health of individuals with ESRD, potentially reducing complications and hospitalizations, while also providing healthcare providers with more tools to monitor and treat these patients remotely.
Relevant Companies
- AMGN (Amgen Inc.) - Amgen produces medications and therapies that may be used in the treatment of kidney disease, and this bill could potentially increase the number of patients needing their treatments.
- DHR (Danaher Corporation) - Danaher provides diagnostic tools and technologies that may be used in monitoring patients with dialysis needs, possibly leading to increased demand for their products.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
4 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Apr. 16, 2026 | Introduced in House |
| Apr. 16, 2026 | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.